Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
185.3 USD | +0.81% |
|
-13.25% | +7.56% |
25/06 | Oppenheimer Downgrades ResMed to Market Perform From Outperform | MT |
24/06 | Shares of ResMed, Inspire Medical Down After Eli Lilly Provides Sleep Apnea Study Update | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.56% | 27B | |
+5.52% | 212B | |
+10.44% | 188B | |
+30.99% | 157B | |
+33.74% | 114B | |
+3.46% | 64.01B | |
+1.51% | 48.83B | |
-3.47% | 39.3B | |
+2.33% | 35.97B | |
+18.01% | 23.74B |
- Stock Market
- Equities
- RMD Stock
- News ResMed, Inc.
- Transcript : ResMed Inc., Q2 2024 Earnings Call, Jan 24, 2024